Spots Global Cancer Trial Database for estramustine phosphate sodium
Every month we try and update this database with for estramustine phosphate sodium cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer | NCT00003066 | Breast Cancer | docetaxel estramustine ph... | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | NCT00002775 | Prostate Cancer | docetaxel estramustine ph... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005810 | Prostate Cancer | filgrastim carboplatin docetaxel estramustine ph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | NCT00002775 | Prostate Cancer | docetaxel estramustine ph... | 18 Years - | National Cancer Institute (NCI) | |
| Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00176527 | Prostate Cancer | recombinant int... docetaxel estramustine ph... isotretinoin polyacrylamide ... protein express... immunohistochem... | 18 Years - | Rutgers, The State University of New Jersey | |
| Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer | NCT00003584 | Kidney Cancer | estramustine ph... prednisone vinorelbine tar... | - 120 Years | University of New Mexico | |
| Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | NCT00002775 | Prostate Cancer | docetaxel estramustine ph... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer | NCT00016107 | Adenocarcinoma ... Hormone-resista... Recurrent Prost... Stage IV Prosta... | estramustine ph... docetaxel bevacizumab laboratory biom... | - | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005810 | Prostate Cancer | filgrastim carboplatin docetaxel estramustine ph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate | NCT00083005 | Prostate Cancer | docetaxel estramustine ph... thalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | NCT00014352 | Prostate Cancer Thromboembolism | docetaxel doxorubicin hyd... estramustine ph... ketoconazole warfarin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00052845 | Prostate Cancer | docetaxel estramustine ph... exisulind | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005847 | Prostate Cancer | recombinant int... estramustine ph... isotretinoin mitoxantrone hy... paclitaxel vinorelbine dit... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | NCT00004054 | Prostate Cancer | bicalutamide estramustine ph... etoposide flutamide paclitaxel Luteinizing hor... Radiation thera... warfarin | 18 Years - | Radiation Therapy Oncology Group | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate | NCT00083005 | Prostate Cancer | docetaxel estramustine ph... thalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | NCT00003084 | Prostate Cancer | Doxorubicin Hyd... Estramustine ph... Etoposide Ketoconazole Paclitaxel Vinblastine | 18 Years - | M.D. Anderson Cancer Center | |
| Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | NCT00027859 | Prostate Cancer | docetaxel estramustine ph... ketoconazole therapeutic hyd... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005627 | Prostate Cancer | carboplatin docetaxel estramustine ph... | 18 Years - 85 Years | National Cancer Institute (NCI) | |
| Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | NCT00027859 | Prostate Cancer | docetaxel estramustine ph... ketoconazole therapeutic hyd... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | NCT00003394 | Prostate Cancer | carboplatin endocrine-modul... estramustine ph... goserelin aceta... leuprolide acet... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | NCT00055731 | Prostate Cancer | bicalutamide Goserelin Aceta... docetaxel Estramustine ph... acetylsalicylic... conventional su... radiation thera... | 0 Years - 79 Years | UNICANCER | |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | NCT00003394 | Prostate Cancer | carboplatin endocrine-modul... estramustine ph... goserelin aceta... leuprolide acet... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | NCT00025194 | Prostate Cancer | estramustine ph... ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy | NCT00046826 | Prostate Cancer | docetaxel estramustine ph... thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005048 | Prostate Cancer | estramustine ph... paclitaxel | - | NYU Langone Health | |
| Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005048 | Prostate Cancer | estramustine ph... paclitaxel | - | NYU Langone Health | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | NCT00025194 | Prostate Cancer | estramustine ph... ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | NCT00002721 | Prostate Cancer | doxorubicin hyd... estramustine ph... drug resistance... | 18 Years - | University of New Mexico | |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | NCT00030654 | Prostate Cancer | bicalutamide docetaxel doxorubicin hyd... estramustine ph... flutamide ketoconazole paclitaxel releasing hormo... vinblastine sul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00084565 | Prostate Cancer | estramustine ph... paclitaxel topotecan hydro... | 18 Years - | Fox Chase Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
